{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T11:30:56Z","timestamp":1659094256217},"reference-count":11,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2021,11,26]],"date-time":"2021-11-26T00:00:00Z","timestamp":1637884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hematology Reports"],"abstract":"<jats:p>Fungal infections occurring in immunocompromised patients after immuno-chemotherapy treatment, are often difficult to eradicate and capable of even being fatal. Systemic mycoses affecting severely immunocompromised patients often manifest acutely with rapidly progressive pneumonia, fungemia, or manifestations of extrapulmonary dissemination. Opportunistic fungal infections (mycoses) include several pathogens elements, as Candidiasis, Aspergillosis, Mucormycosis (zygomycosis) and Fusariosis. Prompt diagnosis and effective therapy are needed to improve the associated morbidity and mortality, especially in cases with non-canonical fungal localizations and not responsive to the available antifungal drugs.<\/jats:p>","DOI":"10.4081\/hr.2021.9329","type":"journal-article","created":{"date-parts":[[2021,11,26]],"date-time":"2021-11-26T13:21:00Z","timestamp":1637932860000},"page":"9329","source":"Crossref","is-referenced-by-count":1,"title":["Therapeutic Innovation for Multi-Resistant Candidemics: Synergy of Isavuconazole and Caspofungin Association"],"prefix":"10.3390","volume":"13","author":[{"given":"Andrea","family":"Duminuco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Mauro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe A. M.","family":"Palumbo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Garibaldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Parisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Di Raimondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cinzia","family":"Maugeri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Calogero","family":"Vetro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,11,26]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"7000","DOI":"10.1200\/JCO.2016.34.15_suppl.7000","article-title":"Final results of a phase III randomized trial of CPX-351 versus 7+3 in older patients with newly diagnosed high risk (secondary) AML","volume":"34","author":"Lancet","year":"2016","journal-title":"J Clin Oncol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"560","DOI":"10.3324\/haematol.2011.053058","article-title":"Posaconazole prophylaxis during front-line chemotherapy of acute myeloid leukemia: a single-center, reallife experience","volume":"97","author":"Girmenia","year":"2012","journal-title":"Haematologica"},{"key":"ref3","first-page":"48","article-title":"Detection of 1,3-beta-D glucan for diagnosis of invasive fungal infections in hematooncological patients: usefulness for screening of invasive mycosis and for confirmation of galactomannan positive results","volume":"15","author":"Racil","year":"2009","journal-title":"Klin Mikrobiol Infekc Lek"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ajo.2011.06.020","article-title":"Endogenous fungal endophthalmitis: causative organisms, management strategies, and visual acuity outcomes","volume":"153","author":"Lingappan","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"8869590","DOI":"10.1155\/2020\/8869590","article-title":"Endogenous endophthalmitis: a review of case series published between 2011 and 2020","volume":"2020","author":"Danielescu","year":"2020","journal-title":"Journal of Ophthalmology"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1136\/bjo.2007.133405","article-title":"Ocular candidiasis: a review","volume":"92","author":"Shah","year":"2008","journal-title":"British Journal of Ophthalmology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3109\/02713683.2016.1170857","article-title":"A comparative study of the effects of intravitreal Anidulafungin, Voriconazole, and Amphotericin B in an experimental candida endophthalmitis model","volume":"42","author":"Karagoz","year":"2017","journal-title":"Curr Eye Res"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1592\/phco.27.12.1711","article-title":"Candida endophthalmitis: focus on current and future antifungal treatment options","volume":"27","author":"Khan","year":"2007","journal-title":"Pharmacotherapy"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1080\/09273948.2019.1571613","article-title":"Intravitreal injections of voriconazole for candida endophthalmitis: a case series","volume":"28","author":"Bienvenu","year":"2020","journal-title":"Ocu Immunol Inflam"},{"key":"ref10","first-page":"e01382","article-title":"In vitro combination of isavuconazole with echinocandins against azole-susceptible and -resistant aspergillus spp","volume":"62","author":"Raffetin","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"ref11","first-page":"1015","article-title":"In vitro and in vivo interaction of caspofungin with isavuconazole against candida auris planktonic cells and biofilms","volume":"59","author":"Nagy","year":"2021","journal-title":"bioRxiv"}],"container-title":["Hematology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.pagepress.org\/journals\/index.php\/hr\/article\/download\/9329\/8763","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.mdpi.com\/2038-8330\/13\/4\/9329\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T07:41:34Z","timestamp":1645602094000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2038-8330\/13\/4\/9329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,26]]},"references-count":11,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,11]]}},"alternative-id":["hr.2021.9329"],"URL":"https:\/\/doi.org\/10.4081\/hr.2021.9329","relation":{},"ISSN":["2038-8330"],"issn-type":[{"value":"2038-8330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,26]]}}}